Search results

  • Full text

  • Document type

    • Publication year

  • Organisation

Results: 297
Number of items: 297
  • Open Access
    Moradveisi, L., Huibers, M. J. H., & Arntz, A. (2025). The effectiveness of behavioral activation and antidepressant medication on the reduction of suicidality in patients with major depressive disorder. BMC Psychiatry, 25, Article 737. https://doi.org/10.1186/s12888-025-07220-5
  • Open Access
    Kool, M., van den Eshof, H., Van, R., Dekker, J., Peen, J., & Arntz, A. (2025). Long-term dosage effects of psychodynamic and schema therapy in depressed patients with personality disorders: 18 and 24 months follow-up of a randomized controlled trial. Psychological Medicine, 55, Article e210. https://doi.org/10.1017/S0033291725101025
  • Open Access
    Abeditehrani, H. (2025). Bridging thought and experience: Integrating CBT with psychodrama for social anxiety. [Thesis, externally prepared, Universiteit van Amsterdam].
  • Open Access
    Assmann, N., Jacob, G., Schaich, A., Berger, T., Zindler, T., Betz, L., Borgwardt, S., Arntz, A., Fassbinder, E., & Klein, J. P. (2025). A digital therapeutic for people with borderline personality disorder in Germany (EPADIP-BPD): a pragmatic, assessor-blind, parallel-group, randomised controlled trial. The Lancet Psychiatry, 12(5), 366-376. https://doi.org/10.1016/S2215-0366(25)00063-X
  • Open Access
    Maloney, G., Arntz, A., & Pittenger, C. (2025). The imagery rescripting protocol for obsessive-compulsive disorder (ImRs-OCD): A decade of iterative refinement in treatment sequencing following ERP. Behaviour Research and Therapy, 195, Article 104878. https://doi.org/10.1016/j.brat.2025.104878
  • Open Access
    Lortye, S., Will, J. P., Marquenie, L. A., Lommerse, N. M., Faber, N., Goudriaan, A. E., Arntz, A., & de Waal, M. M. (2025). Effectiveness of treating post-traumatic stress disorder in patients with co-occurring substance use disorder with prolonged exposure, eye movement desensitization and reprocessing or imagery rescripting: A randomized controlled trial. Addiction, 120(11), 2231-2244. https://doi.org/10.1111/add.70097
  • Open Access
    Arntz, A. (2025). Imagery Rescripting: an update of the treatment protocol. Behaviour Research and Therapy, 195, Article 104913. https://doi.org/10.1016/j.brat.2025.104913
  • Open Access
    Mayer, P. L., Westermair, A. L., Assmann, N., Bloo, J., Calvo, N., De Panfilis, C., Fassbinder, E., Ferrer, M., Jacob, G., Richetin, J., Schaich, A., Preti, E., Klein, J. P., & Arntz, A. (2025). Psychometric Evaluation of the Borderline Personality Disorder Checklist. International Journal of Methods in Psychiatric Research, 34(3), Article e70029. https://doi.org/10.1002/mpr.70029
  • Open Access
    Faber, N. N. M., Lortye, S. A., Marquenie, L. A., Goudriaan, A. E., Arntz, A., & de Waal, M. M. (2025). Trauma-related guilt, shame, and trauma type among patients with co-occurring PTSD and SUD. Alcohol, Clinical and Experimental Research, 49(5), 1064-1075. https://doi.org/10.1111/acer.70028
  • Open Access
    Taylor, C. D. J., Helliwell, B., Coleman, R., Sutton, C. J., Hutton, P., Sylvestre, Y., Bird, L., Shields, G., Kelly, J. A., Brandwood-Spencer, T., Boland, A., Sharrock-Ingham, E., Babatunde, B., Beech, A., Vikram, A., Guillemard, S., Arntz, A., Harper, S. F., & Berry, K. (2025). iMAgery Focused Therapy for PSychosis (iMAPS-2): An Assessor-blind Feasibility Randomized Controlled Clinical Trial. Schizophrenia Bulletin, 51(Supplement 3), S317-S335. https://doi.org/10.1093/schbul/sbaf060
Page 3 of 30